Cargando…
Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice
A clinical challenge remains in the treatment of hypoxic–ischemic brain injury in newborns. Nicotinamide adenine dinucleotide (NAD(+)) has beneficial effects in animal models of adult stroke. Here, we aimed to understand the short- and long-term neuroprotective effects of NAD(+)-promoting substance...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548811/ https://www.ncbi.nlm.nih.gov/pubmed/37787108 http://dx.doi.org/10.1177/17590914231198983 |
_version_ | 1785115354321649664 |
---|---|
author | Kawamura, Takuya Singh Mallah, Gagandeep Ardalan, Maryam Chumak, Tetyana Svedin, Pernilla Jonsson, Lina Jabbari Shiadeh, Seyedeh Marziyeh Goretta, Fanny Ikeda, Tomoaki Hagberg, Henrik Sandberg, Mats Mallard, Carina |
author_facet | Kawamura, Takuya Singh Mallah, Gagandeep Ardalan, Maryam Chumak, Tetyana Svedin, Pernilla Jonsson, Lina Jabbari Shiadeh, Seyedeh Marziyeh Goretta, Fanny Ikeda, Tomoaki Hagberg, Henrik Sandberg, Mats Mallard, Carina |
author_sort | Kawamura, Takuya |
collection | PubMed |
description | A clinical challenge remains in the treatment of hypoxic–ischemic brain injury in newborns. Nicotinamide adenine dinucleotide (NAD(+)) has beneficial effects in animal models of adult stroke. Here, we aimed to understand the short- and long-term neuroprotective effects of NAD(+)-promoting substance nicotinamide mononucleotide (NMN) in a well-established brain injury model in neonatal mice. Postnatal day (PND) 9 male and female mice were subjected to cerebral hypoxia–ischemia and treated with saline or NMN (50 mg/kg) immediately after hypoxia–ischemia. At different time points after hypoxia–ischemia, hippocampal NAD(+), caspase-3 activity, protein expression of SIRT1, SIRT6, release of high mobility group box-1 (HMGB1), long-term neuropathological outcome, short-term developmental behavior, and long-term motor and memory function were evaluated. Neonatal hypoxia–ischemia reduced NAD(+) and SIRT6 levels, but not SIRT1, in the injured hippocampus, while HMGB1 release was significantly increased. NMN treatment normalized hippocampal NAD(+) and SIRT6 levels, while caspase-3 activity and HMGB1 release were significantly reduced. NMN alleviated tissue loss in the long-term and improved early developmental behavior, as well as motor and memory function. This study shows that NMN treatment provides neuroprotection in a clinically relevant neonatal animal model of hypoxia–ischemia in mice suggesting as a possible novel treatment for neonatal brain injury. SUMMARY STATEMENT: Neonatal hypoxia–ischemia reduces nicotinamide adenine dinucleotide (NAD(+)) and SIRT6 levels in the injured hippocampus. Hippocampal high mobility group box-1 (HMGB1) release is significantly increased after neonatal hypoxia–ischemia. Nicotinamide mononucleotide (NMN) treatment normalizes hippocampal NAD(+) and SIRT6 levels, with significant decrease in caspase-3 activity and HMGB1 release. NMN improves early developmental behavior, as well as motor and memory function. |
format | Online Article Text |
id | pubmed-10548811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-105488112023-10-05 Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice Kawamura, Takuya Singh Mallah, Gagandeep Ardalan, Maryam Chumak, Tetyana Svedin, Pernilla Jonsson, Lina Jabbari Shiadeh, Seyedeh Marziyeh Goretta, Fanny Ikeda, Tomoaki Hagberg, Henrik Sandberg, Mats Mallard, Carina ASN Neuro Original Papers A clinical challenge remains in the treatment of hypoxic–ischemic brain injury in newborns. Nicotinamide adenine dinucleotide (NAD(+)) has beneficial effects in animal models of adult stroke. Here, we aimed to understand the short- and long-term neuroprotective effects of NAD(+)-promoting substance nicotinamide mononucleotide (NMN) in a well-established brain injury model in neonatal mice. Postnatal day (PND) 9 male and female mice were subjected to cerebral hypoxia–ischemia and treated with saline or NMN (50 mg/kg) immediately after hypoxia–ischemia. At different time points after hypoxia–ischemia, hippocampal NAD(+), caspase-3 activity, protein expression of SIRT1, SIRT6, release of high mobility group box-1 (HMGB1), long-term neuropathological outcome, short-term developmental behavior, and long-term motor and memory function were evaluated. Neonatal hypoxia–ischemia reduced NAD(+) and SIRT6 levels, but not SIRT1, in the injured hippocampus, while HMGB1 release was significantly increased. NMN treatment normalized hippocampal NAD(+) and SIRT6 levels, while caspase-3 activity and HMGB1 release were significantly reduced. NMN alleviated tissue loss in the long-term and improved early developmental behavior, as well as motor and memory function. This study shows that NMN treatment provides neuroprotection in a clinically relevant neonatal animal model of hypoxia–ischemia in mice suggesting as a possible novel treatment for neonatal brain injury. SUMMARY STATEMENT: Neonatal hypoxia–ischemia reduces nicotinamide adenine dinucleotide (NAD(+)) and SIRT6 levels in the injured hippocampus. Hippocampal high mobility group box-1 (HMGB1) release is significantly increased after neonatal hypoxia–ischemia. Nicotinamide mononucleotide (NMN) treatment normalizes hippocampal NAD(+) and SIRT6 levels, with significant decrease in caspase-3 activity and HMGB1 release. NMN improves early developmental behavior, as well as motor and memory function. SAGE Publications 2023-10-03 /pmc/articles/PMC10548811/ /pubmed/37787108 http://dx.doi.org/10.1177/17590914231198983 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Papers Kawamura, Takuya Singh Mallah, Gagandeep Ardalan, Maryam Chumak, Tetyana Svedin, Pernilla Jonsson, Lina Jabbari Shiadeh, Seyedeh Marziyeh Goretta, Fanny Ikeda, Tomoaki Hagberg, Henrik Sandberg, Mats Mallard, Carina Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice |
title | Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice |
title_full | Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice |
title_fullStr | Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice |
title_full_unstemmed | Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice |
title_short | Therapeutic Effect of Nicotinamide Mononucleotide for Hypoxic–Ischemic Brain Injury in Neonatal Mice |
title_sort | therapeutic effect of nicotinamide mononucleotide for hypoxic–ischemic brain injury in neonatal mice |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548811/ https://www.ncbi.nlm.nih.gov/pubmed/37787108 http://dx.doi.org/10.1177/17590914231198983 |
work_keys_str_mv | AT kawamuratakuya therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT singhmallahgagandeep therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT ardalanmaryam therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT chumaktetyana therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT svedinpernilla therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT jonssonlina therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT jabbarishiadehseyedehmarziyeh therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT gorettafanny therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT ikedatomoaki therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT hagberghenrik therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT sandbergmats therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice AT mallardcarina therapeuticeffectofnicotinamidemononucleotideforhypoxicischemicbraininjuryinneonatalmice |